Clinical Trials Sponsored by DynPort Vaccine Company LLC, A GDIT Company

Total 13 results

DynPort Vaccine Company LLC, A GDIT Company

Completed

A New Anthrax Vaccine Administered by the Intramuscular (IM) Route in Healthy Adults

Anthrax

United States
DynPort Vaccine Company LLC, A GDIT Company

Withdrawn

Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine

Venezuelan Equine Encephalitis

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Study to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy Adults

RECOMBINANT BOTULINUM VACCINE A/B

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

Botulism Vaccine

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant

Plague Vaccine

United States
DynPort Vaccine Company LLC, A GDIT Company

Withdrawn

Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B (rBV A/B)

Botulism
DynPort Vaccine Company LLC, A GDIT Company

Completed

Title: Recombinant Plague Vaccine rF1V in Healthy Volunteers

Healthy Volunteers

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V

Pneumonic Plague | Preventive Therapy

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Study of Reactogenicity, Safety, Immunogenicity, and Pock Lesion Formation of a Cell-Cultured Smallpox Vaccine Compared to Dryvax®

Smallpox

United States
Baxalta now part of Shire
DynPort Vaccine Company LLC, A GDIT Company

Completed

A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly

Healthy Volunteers

United States
Baxalta now part of Shire
DynPort Vaccine Company LLC, A GDIT Company

Completed

Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered Intravenously

Healthy Volunteers | Chemical Terrorism | Chemical Warfare

United States
MCM Vaccines B.V.
Merck Sharp & Dohme LLC; Sanofi Pasteur, a Sanofi Company

Completed

Long-term Persistence of Hepatitis B and Pertussis Antibody Responses in Healthy 4 to 5 Year Old Children Previously Vaccinated With Vaxelis® or INFANRIX® Hexa (V419-012)

Hepatitis B | Pertussis
MCM Vaccines B.V.
Merck Sharp & Dohme LLC; Sanofi Pasteur, a Sanofi Company

Completed

Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)

Virus Diseases | Bacterial Infections | Neisseria Meningitidis

Clinical Trials Sponsored by DynPort Vaccine Company LLC, A GDIT Company

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations